Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$404.24M
Operating Margin
-12.22%
TTM Avg
-9.37%
3Y Avg
-14.04%
5Y Avg
-19.79%
Market Cap
$405.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.78%
Market Cap
$397.99M
Operating Margin
-61.09%
TTM Avg
-74.66%
3Y Avg
-94.75%
5Y Avg
-94.75%
Market Cap
$406.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$396.93M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$411.00M
Operating Margin
-7.97%
TTM Avg
-12.49%
3Y Avg
-22.96%
5Y Avg
-27.91%
Market Cap
$411.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | $402.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -12.22% | -9.37% | -14.04% | -19.79% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 0.00% | 0.00% | 0.00% | 2.78% |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -61.09% | -74.66% | -94.75% | -94.75% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -58.53% | -50.96% | -52.76% | -52.76% |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | -7.97% | -12.49% | -22.96% | -27.91% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -193.83% | -263.44% | -320.82% | -550.06% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -2176.65% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 9.96% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
